Related Experiment Video
Updated: Sep 7, 2025
07:47
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.6K
Metabolomic and Transcriptomic Profiling Identified Significant Genes in Thymic Epithelial Tumor
Enyu Tang1, Yang Zhou2, Siyang Liu1
1Department of Thoracic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
Metabolites
|June 23, 2022
Summary
Metabolic patterns in thymic epithelial tumors (TETs) differ, impacting survival. Identifying specific metabolic genes like ASNS and BLVRA may offer new biomarkers for predicting outcomes in thymic cancer patients.
Area of Science:
- Oncology
- Metabolomics
- Transcriptomics
Background:
- Thymomas and thymic carcinomas (TETs) are malignant tumors with poor prognoses when unresectable.
- The metabolic mechanisms driving TET tumorigenesis remain poorly understood.
Purpose of the Study:
- To investigate differential metabolic profiles and their correlation with clinical outcomes in TETs.
- To identify potential metabolic biomarkers for predicting survival in TET patients.
Main Methods:
- Untargeted metabolomics and transcriptomic analyses were performed on cancerous and noncancerous thymic tissues.
- Metabolic scores were developed to quantify individual tumor metabolic patterns.
- Associations between metabolic scores, clinical outcomes, and immune landscape were analyzed.
Main Results:
- Two distinct metabolic patterns were identified in TETs, correlating with clinical outcomes.
- A high metabolic score was linked to poorer survival and an immunosuppressive tumor microenvironment.
- The expression of ASNS and BLVRA, identified from metabolism-related genes, significantly correlated with patient survival.
Conclusions:
- Differential metabolic patterns are integral to TET tumorigenesis and clinical progression.
- Metabolism-related genes, such as ASNS and BLVRA, show potential as prognostic biomarkers for TETs.
- Targeting identified metabolic pathways could offer novel therapeutic strategies for thymic malignancies.
